학술논문
Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator-controlled, multicentre, US-based trial
Document Type
Article
Author
Source
In: The Lancet Infectious Diseases . (The Lancet Infectious Diseases, February 2023, 23(2):233-246)
Subject
Language
English
ISSN
14744457
14733099
14733099